Conclusion
MC twin pregnancies with sIUFD remain complex and high-risk. They should
not be treated as low-risk singleton pregnancies. Women at risk of
developing sepsis (prenatal therapy) should be closely monitored. It is
not clear what gestation to deliver the surviving co-twin; this should
be investigated with a randomised controlled trial but given the
relative rarity of sIUFD this is unlikely to occur. Preterm birth was
the commonest adverse outcome, and more research is required in this
area. Awareness of the importance of CNS imaging, and follow-up, needs
to be increased, and may be aided by better communication between
specialities and hospitals.